PLENARY 2 OF ISPOR 7TH ASIA-PACIFIC CONFERENCE EXAMINES ROLE OF BIG DATA IN REGION’S HEALTH

Published Sep 5, 2016
Growth of Big Data in Asia-Pacific Presents Opportunities and Challenges  Singapore—September 5, 2016—The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) second plenary session for the Society’s 7th Asia-Pacific ConferenceHarnessing the Power of Big Data to Make Better Health Care Decisions in the Asia-Pacific Region—was held this morning in Singapore. Louisa Jorm, PhD, Professor and Director, Centre for Big Data Research in Health, University of New South Wales (UNSW), Sydney, Australia moderated the session. Speakers included:
  • Christopher Chute, MD, DrPH, Bloomberg Distinguished Professor of Health Informatics, Professor of Medicine, Public Health, and Nursing, and Chief Health Research Information Officer, Johns Hopkins Medicine, Johns Hopkins University, Baltimore, MD, USA
  • Yoke Sin Chong, PhD, Chief Executive Officer, Integrated Health Information Systems Pte Ltd, Singapore, Singapore
  • Trish Williams, PhD, Professor and Chair of Digital Health Technologies, Finders University, Adelaide, Australia
Plenary 2 focused on how many health systems in Asia-Pacific are embracing the big data movement with speakers addressing big data from a variety of health care stakeholder viewpoints and regional perspectives. Louisa Jorm, PhD set the stage for by remarking on the growth in health care data availability and use. While the amount of health care data in Asia-Pacific relative to the Western world is somewhat lagging, it is developing rapidly. This growing availability of health care information has provided the opportunity to combine data from different sources and has created a strong demand for data scientists. Christopher Chute, MD, DrPH emphasized the importance of consistency, comparability, and sharing of data sources to allow for more comprehensive research. Dr. Chute offered a number of examples from other sciences as well as from the development of the Systematized Nomenclature of Medicine (SNOMED) and the International Classification of Diseases and Related Health Problems ICD-11 criteria in health care. Yoke Sin Chong, PhD, described how her company, Integrated Health Information Systems, provides health care information and analytics to over 40,000 users in and around Singapore by partnering with other health care organizations in the region. Trish Williams, PhD discussed how the optimal use of big data requires “convergence disruption”—embracing the many new ways that health data are being collected and analyzed, while dealing with the variety of challenges that such data present. Dr. Williams concluded that, “the digital revolution in medicine has just begun; the availability of data will change how health care will be seen.” Additional information on the ISPOR 7th Asia-Pacific Conference can be found here. Interested parties can follow news and developments from the conference on social media using the hashtag #ISPORsingapore.

###

Related Stories

ISPOR Releases Emerging Good Practices Guidance on Quantifying Specialized Knowledge in Healthcare

Nov 6, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that identifies existing structured expert elicitation protocols that can support healthcare decision making and provides important insights on how to choose which protocols may be the most appropriate for different scenarios, such as time-constrained decisions, early-stage technology assessments, and public health policies.

ISPOR Announces 2024 Health Economics and Outcomes Research Award Honorees

Oct 14, 2024

ISPOR—The Professional Society for Health Economics and Outcomes Research announced today the recipients of its 2024 Health Economics and Outcomes Research (HEOR) Scientific and Leadership Awards.

Cracking the Code on Medicare's Drug Price Negotiations

Oct 1, 2024

ISPOR announced the publication of a study that provides estimates of how the Centers for Medicare & Medicaid Services (CMS) may have determined initial price offers for the first 10 drugs selected for Medicare price negotiation. A prepublication version of the study was released online on the same day the CMS announced it reached agreements for lower drug prices.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×